Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.071 | 0.7 |
mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |